Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

The effects of the Affordable Care Act on the practice of psychiatry.

Ebert MH, Findling RL, Gelenberg AJ, Kane JM, Nierenberg AA, Tariot PN.

J Clin Psychiatry. 2013 Apr;74(4):357-61; quiz 362. doi: 10.4088/JCP.12128co1c. No abstract available.

2.

Maintenance of certification in psychiatry.

Ebert MH, Faulkner L, Stubbe DE, Winstead DK.

J Clin Psychiatry. 2009 Oct;70(10):e39. doi: 10.4088/JCP.8122tx1c.

3.

Relationship between Resident-In-Training Examination in psychiatry and subsequent certification examination performances.

Juul D, Schneidman BS, Sexson SB, Fernandez F, Beresin EV, Ebert MH, Winstead DK, Faulkner LR.

Acad Psychiatry. 2009 Sep-Oct;33(5):404-6. doi: 10.1176/appi.ap.33.5.404.

PMID:
19828858
4.

Maintenance of certification in psychiatry.

Ebert MH, Faulkner L, Stubbe DE, Winstead DK.

J Clin Psychiatry. 2009 May;70(5):619-26; quiz 775-6. No abstract available.

5.

Association of a critical CSF tryptophan threshold level with depressive relapse.

Salomon RM, Kennedy JS, Johnson BW, Schmidt DE, Kwentus J, Gwirtsman HE, Ebert MH.

Neuropsychopharmacology. 2003 May;28(5):956-60. Epub 2003 Mar 19.

6.

Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects.

Kennedy JS, Gwirtsman HE, Schmidt DE, Johnson BW, Fielstein E, Salomon RM, Shiavi RG, Ebert MH, Parris WC, Loosen PT.

Life Sci. 2002 Aug 23;71(14):1703-15.

PMID:
12137916
7.

Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze.

Zhang ZJ, Schmidt DE, de Paulis T, Trivedi BL, Onaivi ES, Ebert MH, Hewlett WA.

Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):571-8.

PMID:
11509218
8.

Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans.

Kennedy JS, Polinsky RJ, Johnson B, Loosen P, Enz A, Laplanche R, Schmidt D, Mancione LC, Parris WC, Ebert MH.

J Clin Psychopharmacol. 1999 Dec;19(6):513-21.

PMID:
10587286
9.

Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys.

Clarke AS, Ebert MH, Schmidt DE, McKinney WT, Kraemer GW.

Biol Psychiatry. 1999 Jul 15;46(2):221-8.

PMID:
10418697
10.

Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.

Hewlett WA, Trivedi BL, Zhang ZJ, de Paulis T, Schmidt DE, Lovinger DM, Ansari MS, Ebert MH.

J Pharmacol Exp Ther. 1999 Jan;288(1):221-31.

PMID:
9862774
11.
12.

Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain.

Hewlett WA, Fridman S, Trivedi BL, Schmidt DE, de Paulis T, Ebert MH.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Feb;22(2):397-410.

PMID:
9608609
13.

Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands.

Hewlett WA, Schmidt DE, Mason NS, Trivedi BL, Ebert MH, de Paulis T.

Nucl Med Biol. 1998 Feb;25(2):141-53.

PMID:
9468029
14.

Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.

Hewlett WA, de Paulis T, Mason NS, Schmidt DE, Trivedi BL, Zhang ZJ, Ebert MH.

Chem Pharm Bull (Tokyo). 1997 Dec;45(12):2079-84.

PMID:
9433779
15.

Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.

Schmidt DE, Ebert MH, Lynn JC, Whetsell WO Jr.

J Neural Transm (Vienna). 1997;104(8-9):875-85.

PMID:
9451719
16.

Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.

Geracioti TD Jr, Loosen PT, Ekhator NN, Schmidt D, Chambliss B, Baker DG, Kasckow JW, Richtand NM, Keck PE Jr, Ebert MH.

Depress Anxiety. 1997;6(3):89-94.

PMID:
9442982
17.

Elevated plasma gamma-aminobutyric acid (GABA) levels in individuals with either Prader-Willi syndrome or Angelman syndrome.

Ebert MH, Schmidt DE, Thompson T, Butler MG.

J Neuropsychiatry Clin Neurosci. 1997 Winter;9(1):75-80.

18.

Rearing experience and biogenic amine activity in infant rhesus monkeys.

Clarke AS, Hedeker DR, Ebert MH, Schmidt DE, McKinney WT, Kraemer GW.

Biol Psychiatry. 1996 Sep 1;40(5):338-52.

PMID:
8874834
19.

Fasting and postprandial cerebrospinal fluid glucose concentrations in healthy women and in an obese binge eater.

Geracioti TD, Loosen PT, Ebert MH, Schmidt D, Ekhator NN.

Int J Eat Disord. 1995 Dec;18(4):365-9.

PMID:
8580923
20.

Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies.

Geracioti TD Jr, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE, Orth DN.

Neuroendocrinology. 1994 Dec;60(6):635-42.

PMID:
7535389
21.

Lack of effect of chronic developmental lead treatment on biogenic amines and metabolites in monkey cerebrospinal fluid.

Ferguson SA, Kraemer GW, Bowman RE, Schmidt DE, Ebert MH.

Neurotoxicol Teratol. 1993 Jul-Aug;15(4):229-35.

PMID:
8413076
22.

High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain.

Kessler RM, Votaw JR, Schmidt DE, Ansari MS, Holdeman KP, de Paulis T, Clanton JA, Pfeffer R, Manning RG, Ebert MH.

Life Sci. 1993;53(3):241-50.

PMID:
8321085
23.

High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.

Kessler RM, Ansari MS, de Paulis T, Schmidt DE, Clanton JA, Smith HE, Manning RG, Gillespie D, Ebert MH.

J Nucl Med. 1991 Aug;32(8):1593-600.

24.
27.

Disturbances of noradrenergic systems in normal weight bulimia: relationship to diet and menses.

Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR.

Biol Psychiatry. 1990 Jan 1;27(1):4-21.

PMID:
2297551
28.

Isoproterenol infusion test in anorexia nervosa: assessment of pre- and post-beta-noradrenergic receptor activity.

Kaye WH, George DT, Gwirtsman HE, Jimerson DC, Goldstein DS, Ebert MH, Lake CR.

Psychopharmacol Bull. 1990;26(3):355-9.

PMID:
2274636
29.
30.

Decreased caloric intake in normal-weight patients with bulimia: comparison with female volunteers.

Gwirtsman HE, Kaye WH, Obarzanek E, George DT, Jimerson DC, Ebert MH.

Am J Clin Nutr. 1989 Jan;49(1):86-92.

PMID:
2912015
31.

Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia.

Gwirtsman HE, Kaye WH, George DT, Jimerson DC, Ebert MH, Gold PW.

Arch Gen Psychiatry. 1989 Jan;46(1):61-9.

PMID:
2535925
32.

Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.

Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.

Psychopharmacol Bull. 1989;25(3):433-8. Review.

PMID:
2533990
33.

[125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.

Janowsky A, De Paulis T, Clanton JA, Smith HE, Ebert MH, Kessler RM.

Eur J Pharmacol. 1988 May 20;150(1-2):203-5. No abstract available.

PMID:
3402540
34.

Excitotoxins and the NMDA-receptor exciting times for neuroscience research.

Tacke U, Ebert MH.

Nord Med. 1988;103(6-7):192-3, 197. No abstract available.

PMID:
2837725
35.

CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain.

Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH.

Biol Psychiatry. 1988 Jan 1;23(1):102-5. No abstract available.

PMID:
2447961
36.

Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.

Kaye WH, Berrettini WH, Gwirtsman HE, Chretien M, Gold PW, George DT, Jimerson DC, Ebert MH.

Life Sci. 1987 Nov 2;41(18):2147-55.

PMID:
2823041
37.

Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.

Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW.

J Clin Endocrinol Metab. 1987 Feb;64(2):203-8.

PMID:
3491830
38.

Caloric intake necessary for weight maintenance in anorexia nervosa: nonbulimics require greater caloric intake than bulimics.

Kaye WH, Gwirtsman HE, Obarzanek E, George T, Jimerson DC, Ebert MH.

Am J Clin Nutr. 1986 Oct;44(4):435-43.

PMID:
3766430
39.

Sleep EEG in Korsakoff's psychosis and Alzheimer's disease.

Martin PR, Loewenstein RJ, Kaye WH, Ebert MH, Weingartner H, Gillin JC.

Neurology. 1986 Mar;36(3):411-4.

PMID:
3951711
40.

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ.

N Engl J Med. 1985 May 30;312(22):1418-21.

PMID:
2581135
41.

Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa.

Kaye WH, Jimerson DC, Lake CR, Ebert MH.

Psychiatry Res. 1985 Apr;14(4):333-42.

PMID:
3860886
42.

Effects of alcohol on cerebrospinal fluid norepinephrine in rhesus monkeys.

Kraemer GW, Lake CR, Ebert MH, McKinney WT.

Psychopharmacology (Berl). 1985;85(4):444-8.

PMID:
3927341
43.

Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional state.

Kaye WH, Gwirtsman HE, Lake CR, Siever LJ, Jimerson DC, Ebert MH, Murphy DL.

Psychopharmacol Bull. 1985;21(3):419-23. No abstract available.

PMID:
2994154
44.

Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa.

Kaye WH, Ebert MH, Gwirtsman HE, Weiss SR.

Am J Psychiatry. 1984 Dec;141(12):1598-601.

PMID:
6209991
45.

Alpha-adrenergic receptors in orthostatic hypotension syndromes.

Kafka MS, Polinsky RJ, Williams A, Kopin IJ, Lake CR, Ebert MH, Tokola NS.

Neurology. 1984 Aug;34(8):1121-5.

PMID:
6087206
46.

Decreased 6-hydroxymelatonin excretion in Korsakoff's psychosis.

Martin PR, Higa S, Burns RS, Tamarkin L, Ebert MH, Markey SP.

Neurology. 1984 Jul;34(7):966-8.

PMID:
6539875
48.

Abnormalities in CNS monoamine metabolism in anorexia nervosa.

Kaye WH, Ebert MH, Raleigh M, Lake R.

Arch Gen Psychiatry. 1984 Apr;41(4):350-5.

PMID:
6200083
49.

Provocative drug testing in Tourette's syndrome: d- and l-amphetamine and haloperidol.

Caine ED, Ludlow CL, Polinsky RJ, Ebert MH.

J Am Acad Child Psychiatry. 1984 Mar;23(2):147-52. No abstract available.

PMID:
6585416
50.

Effects of clonidine on central and peripheral catecholamine metabolism.

Martin PR, Ebert MH, Gordon EK, Linnoila M, Kopin IJ.

Clin Pharmacol Ther. 1984 Mar;35(3):322-7.

PMID:
6199153

Supplemental Content

Loading ...
Support Center